🇳🇴
Norway
420 companies trackedNorway's biotech sector is concentrated in Oslo, with strong expertise in radiopharmaceuticals, diagnostics, and immunotherapy. Companies like Algeta (acquired by Bayer for $2.9B) have proven the Norwegian ecosystem can produce world-class biotech.
Companies
420
Total Raised
$2.1B
Top Stage
Phase 2
Top Focus
Oncology
📍 Oslo📍 Bergen📍 Trondheim📍 Tromsø
🇳🇴
Coming soon
We're tracking 420 companies in Norway — data is being loaded.
Want early access?
🌍 Nearby countries
Are you a Norway biotech?
Claim your profile for free — control your company page, post updates, and connect with investors.
